Link to this page
Ontology of Cardiovascular Drug Adverse Events
Last uploaded:
December 29, 2016
Jump to:
| Id | http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000002061
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000002061
|
|---|---|
| Preferred Name | Muscle Spasticity [Disease/Finding] |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Muscle Spasticity [Disease/Finding]
|
|---|---|
| prefLabel |
Muscle Spasticity [Disease/Finding]
|
| SNOMED_CID |
221360009
|
| NUI |
N0000002061
|
| code |
C4300
|
| prefixIRI |
NDF-RT:N0000002061
|
| RxNorm_CUI |
1024482
|
| subClassOf | |
| imported from | |
| MeSH_CUI |
M0014243
|
| MeSH_DUI |
D009128
|
| type | |
| MeSH_Name |
Muscle Spasticity
|
| UMLS_CUI |
C0026838
|
| Display_Name |
Muscle Spasticity
|
| MeSH_Definition |
A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |